期刊文献+

1型11β-羟基类固醇脱氢酶在实验性2型糖尿病大鼠模型骨骼肌中的表达及意义 被引量:2

Expression of 11β-hydroxysteroid dehydrogenase 1 in skeletal muscle in rats with type 2 diabetes
下载PDF
导出
摘要 目的:探讨糖皮质激素代谢酶1型11β-羟基类固醇脱氢酶(11β-HSD1)及其受体(GR)在2型糖尿病大鼠骨骼肌蛋白表达的改变及意义。方法:Wistar大鼠随机分为对照组及模型组。高脂饮食联合链脲佐菌素(STZ)(30mg·kg-1)2次腹腔注射建立糖尿病模型。造模8周后大鼠剪尾取血,氧化酶法检测空腹血糖水平;放射免疫法检测空腹胰岛素水平,并计算胰岛素相关指数。Western blotting检测11β-HSD1和GR的蛋白表达。结果:与正常对照组比较,模型组的胰岛素分泌指数(IS)、胰岛素敏感指数(ISI)及HOMAβ细胞分泌指数(HβCI)明显下降(P<0.05),而胰岛素抵抗指数(IRI)显著升高(P<0.05),表明模型组有明显的胰岛素抵抗,合并有胰岛素分泌不足。与对照组比较,模型组骨骼肌组织中11β-HSD1及GR的蛋白表达增加(P<0.05)。结论:高脂饮食联合小剂量STZ注射建立的实验性糖尿病模型具有高血糖、胰岛素分泌功能受损及胰岛素抵抗特征;糖尿病模型骨骼肌组织中11β-HSD1及GR的蛋白表达显著增加。 Objective To investigate the changes of the expression of corticosteroids metabolic enzymes 11β-hydroxysteroid dehydrogenase 1(11β-HSD1)and glucocorticoid receptor(GR)in skeletal muscle in type 2 diabetic rat model and significance.Methods The Wistar rats were devided into control and type 2diabetic model groups.The models were built with a combination of high fat diet (HFD)and multiple low dose of STZ (30mg·kg-1,twice)injection.8weeks later,the blood of rats were colleted by cutting their tail,the blood glucose was tested with the method of oxidizing enzyme.According to the serologic test and the relevant index of insulin,the damage of islet and the secretion of insulin were determined.The protein expressions of corticosteroids metabolic enzymes 11β-HSD1 and GR in skeletal muscle were examined by Western blotting analysis. Results Compared with control group,the insulin secretion (IS),insulin sensitivity index (ISI)andsecretion index of HOMAβcell(HβCI)were decreased significantly(P〈0.05),while the insulin resistance index(IRI)was increased significantly(P〈0.05).The protein expressions of 11β-HSD1and GR in model group were higher than those in control group (P〈0.05).Conclusion The type 2diabetic model built with a combination of HFD and multiple low dose of STZ injection has the characteristics of high blood glucose,damage of IS function and insulin resistance.In the type 2diabeic models the protein expressions of 11β-HSD1and GR are significantly increased.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期875-878,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30772604) 吉林省科技发展计划项目资助课题(20070728-2)
关键词 2型糖尿病 胰岛素抵抗 1型11β-固醇脱氢酶 糖皮质激素 糖皮质激素受体 type 2 diabetes mellitus insulin resistance 11 -hydroxysteroid dehydrogenase type 1 glucocorticoids glueoeorticoid receptors
  • 相关文献

参考文献14

  • 1Dallman MF, Akana SF, Pecoraro NC, et al. Glucocorticoids, the etiology of obesity and the metabolic syndrome [J]. Curr Alzheimer Res, 2007, 4 (2): 199- 204.
  • 2Tomlinson JW, Stewart PM. Modulation of glucocorticoid action and the treatment of type-2 diabetes [J].Best Pract Res Clin Endocrinol Metab, 2007, 21 (4): 607-619.
  • 3Yang LY, Zhou Z, Han JZ, et al. Discovery of novel dual functional agent as PPARy agonist and 11β-HSDI inhibitor for the treatment of diabetes [J]. Bioorg Med Chem, 2009, 17 (15): 5722-5732.
  • 4Stimson RH, Walker BR. Glucocorticoids and 11betahydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome [J]. Minerva Endoerinol, 2007, 32 (3): 141-159.
  • 5Drake AJ, Livingstone DE, Andrew R, et al. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats [J]. Endocrinology, 2005, 146 (2):913-919.
  • 6Hermanowski Vosatka A, Balkovec JM, Cheng K, et al. 11beta HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice [J]. J Exp Med, 2005, 202 (4): 517-527.
  • 7Henness S. Pharmacological interventions in the prevention of type 2 diabetes[J]. Curr Opin Endocrinol Diabetes Obes, 2007, 14 (2): 166-169.
  • 8Virally M, Blickle JF, Girard J, et al. Type 2 diabetes mellitus,, epidemiology, pathophysiology, unmet needs and therapeutical perspectives [J]. Diabetes Metab, 2007, 33 (4): 231- 244.
  • 9Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocortieoid receptor function and tissue sensitivity to glucocorticoids[J].Endocr Rev, 1996, 17 (3): 245-261.
  • 10Walker BR, Andrew R. Tissue production of cortisol by 11betabydroxysteroid dehydrogenase type 1 and metabolic disease[J]. Ann NY Acad Sci, 2006, 1083:165-184.

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部